During the past decade, Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut" are "Cardiovascular Disease" (2 trials), "Acute Respiratory Infection" (1 trials), "Clostridium Difficile Infection" (1 trials), "Influenza A" (1 trials) and "Respiratory Syncytial Virus" (1 trials). Many other conditions were trialed in "Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut" in a lesser frequency.

Most popular intervention types in "Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut" are "Drug" (4 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "bococizumab (PF-04950615)" (2 trials), "Clostridium difficile vaccine" (1 trials), "Nasal Swab Sample" (1 trials) and "Pimodivir 600 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".